The final, formatted version of the article will be published soon.
PERSPECTIVE article
Front. Endocrinol.
Sec. Clinical Diabetes
Volume 16 - 2025 |
doi: 10.3389/fendo.2025.1524567
This article is part of the Research Topic Digital Technology in the Management and Prevention of Diabetes: Volume II View all 7 articles
A Successful Remote Patient Monitoring Program for Diabetes
Provisionally accepted- 1 School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- 2 Department of Emergency Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- 3 UCHealth Diabetes and Endocrinology Clinic, Aurora, Colorado, United States
The prevalence of diabetes continues to rise in the United States along with a shortage of endocrinologists. One proposed solution to this challenge is to deliver more specialty health care services through remote patient monitoring (RPM). Here, we describe our initial experience with an RPM program for diabetes care at the University of Colorado. We enrolled 211 patients with primarily uncontrolled type 2 diabetes into the Diabetes Home and Remote Care Program (DHRCP). Remote care replaced traditional brick-and-mortar care while patients were enrolled. A certified diabetes care and education specialists (CDCES) contacted patients every 1-2 weeks to provide lifestyle coaching and assess medication compliance. With oversight from an endocrinologist, frequent medication adjustments were made by the CDCES. Analysis performed on 106 (50.2%) patients who met graduation criteria and had a hemoglobin A1c (HbA1c) completed upon program graduation showed an average decrease in HbA1c from 10.4% to 7.0% (p<0.001). Overall, our results demonstrate that RPM is an effective care model for improving glycemic control in patients with diabetes.
Keywords: Diabetes Mellitus, Remote patient monitoring (RPM), technology in diabetes, Cloud based management, Health care program, diabetes management
Received: 07 Nov 2024; Accepted: 22 Jan 2025.
Copyright: © 2025 Sawyer, Saxon, Zane, Patel, Mcdermott, Singh and Lawler. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Helen M Lawler, UCHealth Diabetes and Endocrinology Clinic, Aurora, CO 80045, Colorado, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.